Search

everythinglearnresearchcommunity

for

Search:↓

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Histone modification is key in treating chronic inflammatory skin diseases.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Erdr1 could be a new marker for diagnosing hair loss.

New treatments for hair loss show promise but need more research to confirm safety and effectiveness.

Eating less sugar, milk, and saturated fats and more vegetables and fish may help treat and prevent acne.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

People with alopecia areata often have thyroid autoimmunity.

Talquetamab may cause hair loss and skin issues.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

New genetic discoveries may lead to better treatments for alopecia areata.

Treating H. pylori infection might help cure alopecia areata.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Stem cells and their secretions could potentially treat stress-induced hair loss, but more human trials are needed.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Combining epinephrine with a steroid may help regrow hair in severe alopecia areata cases.

CBG may help with various medical conditions but needs more human research to confirm safety and effectiveness.